Hikma Pharmaceuticals (HIK)

 

HIK Share PerformanceMore

52 week high2,703.0 02/08/16
52 week low1,575.0 04/11/16
52 week change 107.0 (5.65%)
4 week volume14,931,489 27/02/17

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

FTSE recovers despite Trump healthcare concerns

The blue-chip index recovered some ground this afternoon as investors put concerns over a potential legislative roadblock f...

Director/PDMR Shareholding

RNS Number: 3051A Hikma Pharmaceuticals Plc 23 March 2017 Notification and public disclosure of transactions by persons discharging managerial responsibilities The attached individual notification made under article 19.1 of the Market Abuse Regulation (" MAR ") relates to the disposal of Ordinary Shares of 10 pence each in Hikma Pharmaceuticals PLC by the ...

Broker views: Pharmaceuticals

HSBC has downgraded its recommendation on Hikma Pharma (LON:HIK) to reduce (from hold) saying that it remains co...

Broker Forecast - Peel Hunt issues a broker note on Hikma Pharmaceuticals PLC

Peel Hunt today reaffirms its buy investment rating on Hikma Pharmaceuticals PLC (LON:HIK) and raised its price targe...

Broker Forecast - HSBC issues a broker note on Hikma Pharmaceuticals PLC

HSBC today downgrades its investment rating on Hikma Pharmaceuticals PLC (LON:HIK) to reduce (from hold) and left ...

Broker Forecast - JP Morgan Cazenove issues a broker note on Hikma Pharmaceuticals PLC

JP Morgan Cazenove today downgrades its investment rating on Hikma Pharmaceuticals PLC (LON:HIK) to neutral (from...

Miners dominate FTSE on upbeat Chinese data

Miners were boosted by positive Chinese data with Rio Tinto (RIO), Glencore (GLEN) and Anglo American (AAL) makin...

FTSE tends higher ahead of Fed as Hikma flies

London equities tended cautiously higher in early deals as traders looked mostly beyond a string of corporate news to the U...

Fundamental DataMore

P/E ratio30.09
EPS66.5
Dividend yield1.649 %

Latest discussion posts More

  • Re: UpDown

    "3 reasons for fall" "dir sale 43k " - valid, but after the amount of shares bought by directors over the winter, as has been pointed out, this is minute. And it was falling ...
    24-Mar-2017
    Hardboy
  • Re: UpDown

    This time last year,HIK dropped to around #16 after results and I bought in.Unfortunately it marched all the way up to about #25 and I didn't take profit and it came back ...
    24-Mar-2017
    bamboozled
  • Re: UpDown

    Relentless drop looks very odd. Broker forecasts are all over the place: the lowest is HSBC's #18, but Barclays still haven't revised their target of #34 from Dec 16. They ...
    24-Mar-2017
    sapito

Users' HoldingsMore

Users who hold Hikma Pharmaceuticals also hold..
LLOYDS GRP.30%
GLAXOSMITHKLINE28%
RDS 'B'26%
BP25%
VODAFONE GRP.24%

Codes & Symbols

ISINGB00B0LCW083
SymbolsHIK, LSE:HIK, HIK.L, HIK:LN, LON:HIK, XLON:HIK